Skip to content
Monday, June 27, 2022
Latest:
  • KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
  • The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
  • AlumiFuel Reduces the Authorized Number of Shares
  • Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
  • FACT, Inc. Announces Patricia Trompeter as CEO
Biotech Research Report

Biotech Research Report

Know First, Act First

  • Covid-19
  • General
  • Cannabis
  • Fiscal & Financing
  • Pharmaceutical
  • Trending

BIOTCHNO

BIOTCHNO Fiscal & Financing 

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020

February 11, 2021April 8, 2021 Bachittar

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020 Canada NewsWire VANCOUVER, BC

Read more
BIOTCHNO General 

Jubilant Biosys and Yale University announce collaboration to accelerate multiple small molecule discovery programs

February 9, 2021April 15, 2021 Bachittar

  Canada NewsWire NEW HAVEN, Conn.and BENGALURU,India,Feb. 9, 2021/CNW/ — Today, Jubilant Biosys andYale Universityhave announced a research collaboration for

Read more
BIOTCHNO General 

Transnetyx Announces Acquisition of BrainBits®

February 8, 2021April 16, 2021 Bachittar

  Canada NewsWire MEMPHIS, Tenn.,Feb. 8, 2021/CNW/ — Transnetyx, a global leader in automated genotyping services, today announced the acquisition

Read more
BIOTCHNO General 

The Valens Company Provides Operational and Corporate Update

February 5, 2021April 15, 2021 Desiree Justice

Canada NewsWire KELOWNA, BC,Feb. 5, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company”or“The Valens Company”),a leading manufacturer of cannabis

Read more
BIOTCHNO General 

Gold Mountain Mining Announces $5.0 Million Brokered Private Placement

February 1, 2021April 15, 2021 vanessa

Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TOTHE UNITED STATES/ VANCOUVER, BC, Feb. 1, 2021/CNW/

Read more
BIOTCHNO Pharmaceutical 

Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China

January 26, 2021April 15, 2021 vanessa

Canada NewsWire BOSTON and BEIJING, Jan. 26, 2021/CNW/ —Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for

Read more
BIOTCHNO Trending 

Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time

January 25, 2021April 15, 2021 vanessa

Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time TOKYO, Jan 26, 2021 – (JCN Newswire)

Read more
BIOTCHNO General 

NeuCyte and Mount Sinai Enter Collaboration Agreement

January 19, 2021April 15, 2021 vanessa

Canada NewsWire SAN CARLOS, Calif.,Jan. 19, 2021/CNW/ —NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological

Read more
BIOTCHNO Pharmaceutical 

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium

January 11, 2021May 24, 2021 vanessa

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium TOKYO, Jan 12, 2021 – (JCN Newswire) – Eisai

Read more
BIOTCHNO General 

EXUMA Biotech Announces Collaboration with Moffitt Cancer Center for the Development of a Rapid-Point-Of-Care SC CAR-T Program

January 11, 2021April 15, 2021 vanessa

Canada NewsWire WEST PALM BEACH, Fla.,Jan. 11, 2021/CNW/ — EXUMA Biotech Corp., a clinical-stage biotechnology company discovering and developing chimeric antigen

Read more
  • ← Previous
  • Next →

Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)
BIOTCHNO Cannabis 

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO Cannabis 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057